| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |